C. Mark B. EDWARDS

Subcutaneous glucagon-like peptide-1 (7-36) amide is insulinotropic and can cause hypoglycaemia in fasted healthy subjects

C. Mark B. EDWARDS, Jeannie F. TODD, Mohammad A. Ghatei et al. · Clinical Science · 1998 · 57 citations

Medicine, Endocrinology, Pharmacology +12

Diet-induced change in fatty acid composition of plasma triacylglycerols is not associated with change in glucagon-like peptide 1 or insulin sensitivity in people with type 2 diabetes

Audrey E. Brynes, C. Mark B. EDWARDS, Arvind Jadhav et al. · American Journal of Clinical Nutrition · 2000 · 48 citations · Full text

Life Sciences, Endocrinology, Nutritional Sciences +17

Subcutaneous glucagon-like peptide-1 improves postprandial glycaemic control over a 3-week period in patients with early Type 2 diabetes

Jeannie F. TODD, C. Mark B. EDWARDS, Mohammad A. Ghatei et al. · Clinical Science · 1998 · 21 citations

Medicine, Endocrinology, Pharmacology +17